RxDoctor Payments Data

Kris Abeln, MD

Orthopaedic Surgery · New Albany, INNPI 1851502199

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $42,800 of the $68,326 with a category attached, or 62.6%. Linvatec Corporation accounts for 72.1% of it on its own, with 30 other manufacturers making up the rest. Reporting peaked in 2023 at $19,396 and has fallen 81.7% since, to $3,558 in 2025. Among orthopaedic surgery clinicians in IN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$68,326in general payments, 2019–2025

Across 233 payments — averaging $293.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Linvatec Corporation$49K
  • Arthrex$7K
  • Alpha Orthopedic Systems$5K
  • Pacira Therapeutics, Inc.$3K
  • Medacta USA, Inc.$1K
  • Encore Medical, LP$387
  • plus $2K from 25 others
$6,600in research payments, 2019–2025

Across 2 payments — averaging $3300.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Linvatec Corporation$7K

What the payments were for

  • Consulting fees$42,80063%
  • Speaking & faculty fees$2,5004%
  • Travel & lodging$11,21716%
  • Food & beverage$5,9999%
  • Education$5,8109%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$68,326 in reported general payments places this provider in the 90th percentile of 400 orthopaedic surgery providers in Indiana.

See all orthopaedic surgery providers in Indiana

Medicare billing

Part B allowed, 2024
$204,006
Medicare patients
314
Services billed
2,327

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib25$727
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen101$610
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen51$263
Meloxicam108$228
Promethazine Hcl78$128
Naproxen30$75
Cephalexin67$74
Tramadol Hcl26$53
Amoxicillin13$7

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in New Albany

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →